These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 978319)

  • 41. [Congenital immunodeficiency with adenosine deaminase and purine nucleoside phosphorylase deficiency].
    Sakura N; Usui T; Ito K
    Nihon Rinsho; 1977 Aug; 35(8):2564-80. PubMed ID: 411964
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparative characterization of B-lymphoblastoid cell lines in adenosine deaminase deficiency and its heterozygote.
    Sawami H; Toyokawa Y; Ito K; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):721-9. PubMed ID: 2618547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase.
    Hershfield MS; Buckley RH; Greenberg ML; Melton AL; Schiff R; Hatem C; Kurtzberg J; Markert ML; Kobayashi RH; Kobayashi AL
    N Engl J Med; 1987 Mar; 316(10):589-96. PubMed ID: 3807953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunodeficiency secondary to adenosine deaminase deficiency and purine nucleoside phosphorylation deficiency.
    Carson DA; Carrera CJ
    Semin Hematol; 1990 Jul; 27(3):260-9. PubMed ID: 2115692
    [No Abstract]   [Full Text] [Related]  

  • 45. Severe combined immunodeficiency and adenosine deaminase deficiency: failure of enzyme replacement therapy.
    Ziegler JB; Lee CH; Van der Weyden MB; Bagnara AS; Beveridge J
    Arch Dis Child; 1980 Jun; 55(6):452-7. PubMed ID: 7436484
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adenosine deaminase messenger RNAs in lymphoblast cell lines derived from leukemic patients and patients with hereditary adenosine deaminase deficiency.
    Adrian GS; Hutton JJ
    J Clin Invest; 1983 Jun; 71(6):1649-60. PubMed ID: 6134754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ADA and PNP deficiencies: how it all began.
    Giblett ER
    Ann N Y Acad Sci; 1985; 451():1-8. PubMed ID: 3935025
    [No Abstract]   [Full Text] [Related]  

  • 48. Complete and partial adenosine deaminase deficiency. Relationship of immune function to metabolite concentrations, enzyme activity, and effects of therapy.
    Hirschhorn R
    Ann N Y Acad Sci; 1985; 451():20-5. PubMed ID: 3907453
    [No Abstract]   [Full Text] [Related]  

  • 49. A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast cell line.
    Uberti J; Peterson WD; Lightbody JJ; Johnson RM
    J Immunol; 1983 Jun; 130(6):2866-70. PubMed ID: 6854019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inosine triphosphate pyrophosphohydrolase deficiency in a kindred with adenosine deaminase deficiency.
    Duley JA; Simmonds HA; Hopkinson DA; Levinsky RJ
    Clin Chim Acta; 1990 May; 188(3):243-52. PubMed ID: 2167185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adenosine deaminase deficiency with normal immune function. An acidic enzyme mutation.
    Daddona PE; Mitchell BS; Meuwissen HJ; Davidson BL; Wilson JM; Koller CA
    J Clin Invest; 1983 Aug; 72(2):483-92. PubMed ID: 6603477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biochemical and functional abnormalities in lymphocytes from an adenosine deaminase-deficient patient during enzyme replacement therapy.
    Hutton JJ; Wiginton DA; Coleman MS; Fuller SA; Limouze S; Lampkin BC
    J Clin Invest; 1981 Aug; 68(2):413-21. PubMed ID: 7263861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A lymphoblastoid cell line from an adenosine deaminase deficient patient established by Epstein-Barr virus.
    Tsuchiya S; Narisawa K; Konno T; Tada K
    Tohoku J Exp Med; 1979 Oct; 129(2):105-10. PubMed ID: 227140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: overview, genetic heterogeneity and therapy.
    Hirschhorn R
    Birth Defects Orig Artic Ser; 1983; 19(3):73-81. PubMed ID: 6418227
    [No Abstract]   [Full Text] [Related]  

  • 55. Adenosine deaminase deficiency: frequency and comparative pathology in autosomally recessive severe combined immunodeficiency.
    Hirschhorn R; Vawter GF; Kirkpatrick JA; Rosen FS
    Clin Immunol Immunopathol; 1979 Sep; 14(1):107-20. PubMed ID: 477037
    [No Abstract]   [Full Text] [Related]  

  • 56. MLC vs CML in a case of T-cell immunodeficiency and ADA deficiency.
    Cohen F
    Birth Defects Orig Artic Ser; 1975; 11(1):486-8. PubMed ID: 125120
    [No Abstract]   [Full Text] [Related]  

  • 57. [Transplantation of T cell-depleted marrow from parents in a case of severe combined immunodeficiency with adenosine deaminase deficiency].
    Yamagami M; Matsuda A; Nakarai T; Katayama K; Saigawa Y; Horita S; Miura M; Kato E; Koizumi S; Taniguchi N
    Rinsho Ketsueki; 1987 Sep; 28(9):1669-74. PubMed ID: 3325660
    [No Abstract]   [Full Text] [Related]  

  • 58. New perspectives in the diagnosis and treatment of adenosine deaminase (ADA) deficiency.
    Levinsky RJ; Davies EG; Simmonds HA; Webster DR; Adinolfi M
    Adv Exp Med Biol; 1984; 165 Pt A():33-8. PubMed ID: 6609527
    [No Abstract]   [Full Text] [Related]  

  • 59. In vivo and in vitro effects of thymosin and adenosine deaminase on adenosine-deaminase-deficient lymphocytes.
    Rubinstein A; Hirschhorn R; Sicklick M; Murphy RA
    N Engl J Med; 1979 Feb; 300(8):387-92. PubMed ID: 310515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Adenosine deaminase deficit in severe combined immunodeficiency (author's transl)].
    Español Borén T; Jacques Castro G; Torán Fuentes N; Vives-Corrons JL
    Sangre (Barc); 1981; 26(6):1129-38. PubMed ID: 6805082
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.